708-1019

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
708 (USA) · Dr. Kim
consented 2013-12-20

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2014-01-01 (study day 13.0); relationship: POSSIBLE

severe assessed

Severe HEADACHE — outcome: RECOVERED/RESOLVED; onset 2013-12-31 (study day 12.0); relationship: POSSIBLE

severe assessed

Severe STUPOR — outcome: RECOVERED/RESOLVED; onset 2014-01-01 (study day 13.0); relationship: POSSIBLE

severe assessed

Severe TRANSIENT ISCHAEMIC ATTACK — outcome: RECOVERED/RESOLVED; onset 2014-01-01 (study day 13.0); relationship: POSSIBLE

mild assessed

Mild VISION BLURRED — outcome: RECOVERED/RESOLVED; onset 2014-01-01 (study day 13.0); relationship: POSSIBLE

Data queries

No data queries.